978 Shares in Danaher Co. (NYSE:DHR) Acquired by Centricity Wealth Management LLC

Centricity Wealth Management LLC bought a new stake in shares of Danaher Co. (NYSE:DHR) during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 978 shares of the conglomerate’s stock, valued at approximately $224,000.

Other hedge funds also recently bought and sold shares of the company. Heck Capital Advisors LLC acquired a new stake in shares of Danaher during the fourth quarter valued at $27,000. Decker Retirement Planning Inc. purchased a new position in Danaher in the 4th quarter valued at about $31,000. Golden State Wealth Management LLC acquired a new stake in shares of Danaher during the 4th quarter worth about $31,000. Strategic Financial Concepts LLC purchased a new stake in shares of Danaher during the fourth quarter worth about $31,000. Finally, Pineridge Advisors LLC grew its holdings in shares of Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of Danaher stock in a transaction that occurred on Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the sale, the senior vice president now directly owns 20,230 shares in the company, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 11.10% of the stock is currently owned by company insiders.

Danaher Price Performance

Danaher stock opened at $208.10 on Friday. The firm has a market capitalization of $150.31 billion, a P/E ratio of 39.41, a PEG ratio of 2.61 and a beta of 0.83. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The firm has a fifty day moving average of $227.21 and a 200-day moving average of $247.52.

Danaher (NYSE:DHR) last released its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same period in the previous year, the firm posted $2.09 earnings per share. As a group, analysts predict that Danaher Co. will post 7.67 EPS for the current year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be paid a dividend of $0.32 per share. This is an increase from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.62%. Danaher’s payout ratio is 20.45%.

Analyst Ratings Changes

A number of analysts recently issued reports on DHR shares. JPMorgan Chase & Co. decreased their target price on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Guggenheim assumed coverage on Danaher in a research note on Thursday, December 19th. They set a “buy” rating and a $275.00 price target on the stock. StockNews.com downgraded Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Raymond James reiterated a “market perform” rating on shares of Danaher in a research report on Monday, February 3rd. Finally, Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 price target for the company in a report on Friday, December 13th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.